Lyra Therapeutics, Inc. (LYRA)

NASDAQ: LYRA · IEX Real-Time Price · USD

4.630

-0.620 (-11.81%)

At close: May 2, 2024, 4:00 PM

4.790

+0.160 (3.46%)

After-hours: May 2, 2024, 7:01 PM EDT

Lyra Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	277	275	100	57	147	-
Market Cap Growth	-	175.60%	76.26%	-61.52%	-	-
Enterprise Value	225	198	3	12	75	-7
PE Ratio	-5.39	-4.39	-1.81	-1.30	-6.66	-
PS Ratio	164.65	176.79	73.32	198.95	-	-
PB Ratio	3.57	3.08	1.24	1.65	1.98	-
P/FCF Ratio	-5.09	-4.28	-2.29	-1.94	-6.43	-
P/OCF Ratio	-5.32	-4.35	-2.30	-2.20	-6.97	-
EV/Sales Ratio	134.14	127.19	2.10	42.38	-	-
EV/EBITDA Ratio	-4.66	-3.18	-0.05	-0.28	-3.40	0.42
EV/EBIT Ratio	-4.66	-3.16	-0.05	-0.28	-3.38	0.42
EV/FCF Ratio	-4.38	-3.08	-0.07	-0.41	-3.27	0.49
Debt / Equity Ratio	0.49	0.30	0.03	0.04	0.03	-0.03
Debt / EBITDA Ratio	-0.55	-0.43	-0.04	-0.03	-0.11	-0.20
Debt / FCF Ratio	-0.52	-0.42	-0.05	-0.05	-0.11	-0.24
Quick Ratio	4.76	5.31	6.86	2.53	15.34	1.95
Current Ratio	4.78	5.35	6.97	2.63	15.54	1.94
Asset Turnover	0.01	0.01	0.01	0.00	0	0
Return on Equity (ROE)	-78.80%	-74.10%	-72.90%	-84.30%	-76.70%	14.20%
Return on Assets (ROA)	-51.90%	-51.90%	-54.40%	-64.00%	-29.30%	-80.90%
Return on Capital (ROIC)	-63.56%	-57.71%	-67.86%	-121.94%	-28.87%	13.76%
Earnings Yield	-24.90%	-22.76%	-55.31%	-76.74%	-15.01%	-
FCF Yield	-26.41%	-23.36%	-43.58%	-51.51%	-15.55%	-
Buyback Yield / Dilution	-73.79%	-64.72%	-132.83%	-51.17%	-4150.62%	-21.68%
Total Shareholder Return	-73.79%	-64.72%	-132.83%	-51.17%	-4150.62%	-21.68%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).